2023
Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
Gaidos J, Al Bawardy B, Farraye F, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohn's & Colitis 360 2023, 5: otad037. PMID: 37559746, PMCID: PMC10407976, DOI: 10.1093/crocol/otad037.Peer-Reviewed Original ResearchMayo endoscopic subscoreEndoscopic scoreEndoscopy scoresCrohn's diseaseRutgeerts scoreChi-square testPouchitis Disease Activity IndexDisease activity indexSimple Endoscopic ScoreEndoscopic scoring systemManagement of patientsPearson's chi-square testMore consistent useIBD practiceEndoscopic subscoreMucosal healingAdult gastroenterologistsMore frequent useUnpaired Student'sClinical practiceTreatment targetsScoring systemWeb-based surveyCase-based conferencesFurther evaluation
2020
Surgical outcomes in aspirin‐exacerbated respiratory disease without aspirin desensitization
Grose E, Lee D, Yip J, Cottrell J, Sykes J, Lee J, Lee J. Surgical outcomes in aspirin‐exacerbated respiratory disease without aspirin desensitization. International Forum Of Allergy & Rhinology 2020, 10: 1149-1157. PMID: 32558318, DOI: 10.1002/alr.22626.Peer-Reviewed Original ResearchConceptsAspirin-exacerbated respiratory diseaseMonoclonal antibody therapyEndoscopic sinus surgeryLund-Kennedy endoscopy scoresSNOT-22 scoresAspirin desensitizationSNOT-22Surgical outcomesRevision ESSSino-Nasal Outcome TestRevision surgeryEndotypes of chronic rhinosinusitisAspirin-exacerbated respiratory disease patientsRevision surgery ratesEffective therapeutic optionLund-KennedyEndoscopy scoresRespiratory diseaseChronic rhinosinusitisSinus surgeryAntibody therapyNasal polyposisRetrospective reviewMedian timeSurgery rates
2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
Faubion WA, Fletcher JG, O'Byrne S, Feagan BG, de Villiers WJ, Salzberg B, Plevy S, Proctor DD, Valentine JF, Higgins PD, Harris JM, Diehl L, Wright L, Tew GW, Luca D, Basu K, Keir ME. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging. The American Journal Of Gastroenterology 2013, 108: 1891. PMID: 24126633, DOI: 10.1038/ajg.2013.354.Peer-Reviewed Original ResearchConceptsComputed tomography enterographySerum IL-22Disease activityFecal calprotectinCrohn's diseaseSerum MMP9Ulcerative colitisCross-sectional imagingCD patientsIL-22Serum matrix metalloproteinase-9Bowel wall inflammationInflammatory disease activitySerum interleukin‐22Inflammatory bowel diseaseFindings of inflammationCrohn's disease activityMatrix metalloproteinase-9Endoscopy subscoreTomography enterographyUC patientsEndoscopy scoresBowel diseaseClinical symptomsWall inflammation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply